세계의 생리활성 단백질 및 펩티드 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 유래별, 용도별, 지역별

Bio Active Protein and Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

US $ 4,995 ￦ 6,999,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,904,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,854,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 생리활성 단백질 및 펩티드 시장 규모는 영양가가 높고 건강한 식품을 요구하는 소비자 증가에 따라 강력한 확대를 이루고 있습니다. 이 성장은 인구동태의 변화, 소비자의 기호의 진화, 생산기술의 진보 등이 함께 향후 10년간 계속될 것으로 예측되고 있습니다.

노화와 관련된 만성 질환 증가로 소비자는 생물학적 활성 단백질과 펩티드를 포함하여 더 건강한식이 요법을 찾습니다. 화장품 및 퍼스널케어 분야에서 이러한 영양소에 대한 소비자의 선호도가 높아지고 있으며 시장 규모가 더욱 확대되고 있습니다. 세계적으로 가처분 소득 수준이 상승하고 1인당 식비가 증가함에 따라 더 많은 소비자가 프리미엄 건강 지향 제품을 구입할 수 있습니다.

건강, 지속가능성, 윤리적인 이유로 채식과 육식을 피하는 경향이 강해지면서 식물 유래 원료, 특히 대두와 완두콩 유래 원료의 인기가 높아지고 있습니다. 또한 식물 유래 단백질은 일반적으로 동물 유래 단백질보다 저렴하고 추출하기 쉽기 때문에 제조업체에게 매력적입니다.

본 보고서에서는 세계의 생리활성 단백질 및 펩티드 시장에 대해 조사했으며, 시장 개요와 함께 유래별, 용도별, 지역별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 생리활성 단백질 및 펩티드 시장 전망(2018-2031년)

• 세계의 생리활성 단백질 및 펩티드 시장 전망, 유래별, 금액(10억 달러)(2018-2031년)
• 세계의 생리활성 단백질 및 펩티드 시장 전망, 용도별, 금액(10억 달러)(2018-2031년)
• 세계의 생리활성 단백질 및 펩티드 시장 전망, 지역별, 금액(10억 달러)(2018-2031년)

제4장 북미의 생리활성 단백질 및 펩티드 시장 전망(2018-2031년)

제5장 유럽의 생리활성 단백질 및 펩티드 시장 전망(2018-2031년)

제6장 아시아태평양의 생리활성 단백질 및 펩티드 시장 전망(2018-2031년)

제7장 라틴아메리카의 생리활성 단백질 및 펩티드 시장 전망(2018-2031년)

제8장 중동 및 아프리카의 생리활성 단백질 및 펩티드 시장 전망(2018-2031년)

제9장 경쟁 구도

• 기업의 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 프로파일
  • BASF SE
  • Seagarden AS
  • ADM
  • Ingredia SA
  • Rousselot SAS
  • Peptan
  • Kerry Group plc
  • CP Kelco
  • Omega Protein Corporation
  • EI Du Pont De Nemours

제10장 부록

JHS

영문 목차

영문목차

The global market for bioactive proteins and peptides is experiencing robust growth as consumers increasingly seek out nutritional and healthy food options. This growth is projected to continue over the coming decade, driven by a combination of demographic shifts, evolving consumer preferences, and advances in production technologies.

Factors Influencing Market Growth

Several key factors are propelling the demand for bioactive proteins and peptides:

• Aging Population: The rise in chronic diseases associated with aging is leading consumers to seek out healthier dietary options that include bioactive proteins and peptides.
• Health and Wellness Trends: There is an increasing consumer preference for these nutrients in the cosmetics and personal care sectors, further expanding the market reach.
• Economic Factors: As disposable income levels rise globally, alongside an increase in per capita food expenditure, more consumers are able to afford premium health-oriented products.
• Plant-Based Trends: Plant source ingredients, particularly from soy and pea, are becoming more popular due to the growing trend towards vegetarian and meat-free diets for health, sustainability, and ethical reasons. Plant-derived proteins are also typically less expensive and easier to extract than animal sources, making them attractive to manufacturers.

Challenges in the Market

Despite robust growth, manufacturers face certain challenges:

• Regulatory Environment: Stringent regulations increase operational costs and affect the overall efficiency of production and distribution.
• Supply Chain Complexity: Issues within the supply chain can also pose significant hurdles for players in this market.

Regional Market Insights

North America is currently the leader in the global bioactive proteins and peptides market, attributed to its high demand for sports and nutritional foods. The busy lifestyle and work culture in this region have increased the consumption of ready-to-eat and functional beverages, creating significant opportunities for market players. However, other regions, including Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan, and the Middle East & Africa, also show promising growth potential.

Market Trends

The trend towards plant-sourced bioactive proteins and peptides is particularly strong, with this segment expected to see substantial year-on-year growth throughout the forecast period. The increasing physiological benefits and consumer preference towards vegetarian food contribute to this trend. Among applications, while functional foods remain popular, functional beverages are anticipated to see higher traction and growth, reflecting consumer desires for convenient, health-enhancing products.

Key Players in the Market

Leading companies in the global bioactive protein and peptides market include Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd., E.I. Du Pont De Nemours and Company, Fonterra Co-operative Group Ltd., Royal DSM, and CHS Inc. These players are at the forefront of addressing consumer demands through innovation and are expanding their market presence through strategic initiatives and extensive research & development activities.

Market Segmentation

The market is segmented based on source and application, offering insights into consumer preferences and product functionality:

By Source

• Plant Source
  • Cereals
  • Legumes

§ Soy Protein Concentrates

§ Soy Protein Isolates

§ Textured Soy Protein

• Pseudo cereals
• Brasssicaceae species
• Others
• Animal Source
  • Dairy products

§ Whey

§ Casein

§ Milk Protein Concentrate

• Egg & Meat
• Gelatin
• Fish & Insects
• Seafood

By Application

• Functional Food
• Functional Beverages
• Dietary Supplements
• Animal Nutrition
• Personal Care
• Others (Printing & Painting)

Table of Contents

1. Executive Summary

• 1.1. Global Bio Active Protein and Peptides Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Bio Active Protein and Peptides Market Outlook, 2018 - 2031

• 3.1. Global Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. Plant
    • 3.1.1.2. Animal
    • 3.1.1.3. Marine
• 3.2. Global Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Functional Food
    • 3.2.1.2. Functional Beverages
    • 3.2.1.3. Dietary Supplements
    • 3.2.1.4. Animal Nutrition
    • 3.2.1.5. Personal Care
    • 3.2.1.6. Others (Printing & Painting)
• 3.3. Global Bio Active Protein and Peptides Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. North America
    • 3.3.1.2. Europe
    • 3.3.1.3. Asia Pacific
    • 3.3.1.4. Latin America
    • 3.3.1.5. Middle East & Africa

4. North America Bio Active Protein and Peptides Market Outlook, 2018 - 2031

• 4.1. North America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Plant
    • 4.1.1.2. Animal
    • 4.1.1.3. Marine
• 4.2. North America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Functional Food
    • 4.2.1.2. Functional Beverages
    • 4.2.1.3. Dietary Supplements
    • 4.2.1.4. Animal Nutrition
    • 4.2.1.5. Personal Care
    • 4.2.1.6. Others (Printing & Painting)
  • 4.2.2. BPS Analysis/Market Attractiveness Analysis
• 4.3. North America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. U.S. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 4.3.1.2. U.S. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.1.3. Canada Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 4.3.1.4. Canada Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Bio Active Protein and Peptides Market Outlook, 2018 - 2031

• 5.1. Europe Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Plant
    • 5.1.1.2. Animal
    • 5.1.1.3. Marine
• 5.2. Europe Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Functional Food
    • 5.2.1.2. Functional Beverages
    • 5.2.1.3. Dietary Supplements
    • 5.2.1.4. Animal Nutrition
    • 5.2.1.5. Personal Care
    • 5.2.1.6. Others (Printing & Painting)
  • 5.2.2. BPS Analysis/Market Attractiveness Analysis
• 5.3. Europe Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Germany Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.2. Germany Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1.3. U.K. Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.4. U.K. Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1.5. France Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.6. France Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1.7. Italy Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.8. Italy Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1.9. Turkey Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.10. Turkey Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1.11. Russia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.12. Russia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1.13. Rest of Europe Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 5.3.1.14. Rest of Europe Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Bio Active Protein and Peptides Market Outlook, 2018 - 2031

• 6.1. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Plant
    • 6.1.1.2. Animal
    • 6.1.1.3. Marine
• 6.2. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Functional Food
    • 6.2.1.2. Functional Beverages
    • 6.2.1.3. Dietary Supplements
    • 6.2.1.4. Animal Nutrition
    • 6.2.1.5. Personal Care
    • 6.2.1.6. Others (Printing & Painting)
  • 6.2.2. BPS Analysis/Market Attractiveness Analysis
• 6.3. Asia Pacific Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. China Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 6.3.1.2. China Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1.3. Japan Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 6.3.1.4. Japan Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1.5. South Korea Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 6.3.1.6. South Korea Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1.7. India Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 6.3.1.8. India Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1.9. Southeast Asia Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 6.3.1.10. Southeast Asia Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1.11. Rest of Asia Pacific Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 6.3.1.12. Rest of Asia Pacific Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Bio Active Protein and Peptides Market Outlook, 2018 - 2031

• 7.1. Latin America Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. Plant
    • 7.1.1.2. Animal
    • 7.1.1.3. Marine
• 7.2. Latin America Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
  • 7.2.1. Key Highlights
    • 7.2.1.1. Functional Food
    • 7.2.1.2. Functional Beverages
    • 7.2.1.3. Dietary Supplements
    • 7.2.1.4. Animal Nutrition
    • 7.2.1.5. Personal Care
    • 7.2.1.6. Others (Printing & Painting)
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Latin America Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Brazil Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 7.3.1.2. Brazil Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1.3. Mexico Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 7.3.1.4. Mexico Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1.5. Argentina Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 7.3.1.6. Argentina Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1.7. Rest of Latin America Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 7.3.1.8. Rest of Latin America Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Bio Active Protein and Peptides Market Outlook, 2018 - 2031

• 8.1. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Source, Value (US$ Bn), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. Plant
    • 8.1.1.2. Animal
    • 8.1.1.3. Marine
• 8.2. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Functional Food
    • 8.2.1.2. Functional Beverages
    • 8.2.1.3. Dietary Supplements
    • 8.2.1.4. Animal Nutrition
    • 8.2.1.5. Personal Care
    • 8.2.1.6. Others (Printing & Painting)
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Middle East & Africa Bio Active Protein and Peptides Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. GCC Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 8.3.1.2. GCC Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1.3. South Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 8.3.1.4. South Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1.5. Egypt Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 8.3.1.6. Egypt Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1.7. Nigeria Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 8.3.1.8. Nigeria Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1.9. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Source, Value (US$ Bn), 2018 - 2031
    • 8.3.1.10. Rest of Middle East & Africa Bio Active Protein and Peptides Market by Application, Value (US$ Bn), 2018 - 2031
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Company Market Share Analysis, 2024
• 9.2. Competitive Dashboard
• 9.3. Company Profiles
  • 9.3.1. BASF SE
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Therapy Portfolio
    • 9.3.1.3. Financial Overview
    • 9.3.1.4. Business Strategies and Development
  • 9.3.2. Seagarden AS
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Therapy Portfolio
    • 9.3.2.3. Financial Overview
    • 9.3.2.4. Business Strategies and Development
  • 9.3.3. ADM
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Therapy Portfolio
    • 9.3.3.3. Financial Overview
    • 9.3.3.4. Business Strategies and Development
  • 9.3.4. Ingredia SA
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Therapy Portfolio
    • 9.3.4.3. Financial Overview
    • 9.3.4.4. Business Strategies and Development
  • 9.3.5. Rousselot S.A.S.
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Therapy Portfolio
    • 9.3.5.3. Financial Overview
    • 9.3.5.4. Business Strategies and Development
  • 9.3.6. Peptan
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Therapy Portfolio
    • 9.3.6.3. Financial Overview
    • 9.3.6.4. Business Strategies and Development
  • 9.3.7. Kerry Group plc
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Therapy Portfolio
    • 9.3.7.3. Financial Overview
    • 9.3.7.4. Business Strategies and Development
  • 9.3.8. CP Kelco
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Therapy Portfolio
    • 9.3.8.3. Financial Overview
    • 9.3.8.4. Business Strategies and Development
  • 9.3.9. Omega Protein Corporation
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Therapy Portfolio
    • 9.3.9.3. Financial Overview
    • 9.3.9.4. Business Strategies and Development
  • 9.3.10. E.I. Du Pont De Nemours
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Therapy Portfolio
    • 9.3.10.3. Financial Overview
    • 9.3.10.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations